AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Resmed DRC

37.260

+0.3600.98%

Volume:534.78K

Turnover:19.89M

Market Cap:54.63B

PE:29.11

High:37.320

Open:36.850

Low:36.720

Close:36.900

Loading ...

Overview Company News Filings

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

Bell Potter: 4 quality stocks now at a discount

Stock Track | ResMed Soars 6.81% in Pre-Market as Analyst Confidence Grows

If I were building my portfolio from scratch, I'd buy these 3 ASX stocks today

ResMed Inc. Stock Rises Monday, Outperforms Market

Market shifts and contrarian opportunities: WAM Leaders on “What’s next”

2 top quality ASX 200 shares to buy after the market selloff

Here's a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!

10 ASX shares to buy after the market selloff

Should I buy Fisher & Paykel or ResMed shares?

ResMed Launches Home Sleep Apnea Test Across US; Shares Fall 3%

MT Newswires Live

ResMed Inc. Stock Falls Thursday, Still Outperforms Market

The top 3 qualities I look for when picking an ASX stock

3 no-brainer ASX 200 shares to buy after the market selloff

Resmed Inc. (RMD): Jim Cramer Says He Likes This Sleep Apnea Treatment Stock

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

The power of compounding: What your ASX share portfolio could become by 2040

Resmed Chief Legal Officer Sells Shares

MT Newswires Live

ResMed Inc. Stock Rises Monday, Outperforms Market

Don't waste this market selloff: Why now could be the time to buy ASX shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RMD.AU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RMD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","market":"AU","secType":"STK","nameCN":"Resmed DRC","latestPrice":37.26,"timestamp":1746166320000,"preClose":36.9,"halted":0,"volume":534783,"delay":0,"nameEN":"Resmed DRC","floatShares":145691036,"shares":1466188140,"eps":1.2798634812286689,"marketStatus":"Market Closed","change":0.36,"latestTime":"05-02 16:12:00 AEST","open":36.85,"high":37.32,"low":36.72,"amount":19886061,"amplitude":0.01626,"askPrice":37.29,"askSize":26,"bidPrice":37.07,"bidSize":580,"shortable":3,"etf":0,"ttmEps":1.2798634812286689,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746403200000},"marketStatusCode":7,"adr":0,"adrRate":1,"exchange":"ASX","adjPreClose":36.9,"dividendRate":0.0082,"openAndCloseTimeList":[[1746144000000,1746165600000]],"volumeRatio":0.25883601211665325,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","floatShares":145691036,"roa":"14.01%","roe":"25.81%","lyrEps":0.969594,"volumeRatio":0.25883601211665325,"shares":1466188140,"dividePrice":0.305616,"high":37.32,"amplitude":0.01626,"preClose":36.9,"low":36.72,"week52Low":26.946,"pbRate":"6.35","psRate":"7.01","week52High":40.661,"institutionHeld":0,"latestPrice":37.26,"committee":0.914191,"eps":1.2798634812286689,"divideRate":0.0082,"volume":534783,"delay":0,"ttmEps":1.2798634812286689,"open":36.85,"prevYearClose":36.689,"prevWeekClose":36.08,"prevMonthClose":36.68,"prevQuarterClose":34.96,"fiveDayClose":36.08,"twentyDayClose":35.63,"sixtyDayClose":38.874},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RMD.AU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525896099","title":"Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525896099","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525896099?lang=en_us&edition=fundamental","pubTime":"2025-04-08 17:04","pubTimestamp":1744103068,"startTime":"0","endTime":"0","summary":"Let’s dig into the relative performance of Masimo  and its peers as we unravel the now-completed Q4 patient monitoring earnings season.Katie Szyman, Chief Executive Officer of Masimo, said “I am extremely excited about the opportunity to lead such an innovative organization as we refocus on our core healthcare business. There are numerous unmet clinical needs that we are well-positioned to address and we have strong momentum behind us. I look forward to interfacing with our customers and discussing our differentiated solutions for patient care. Our 2024 results clearly demonstrate the strong growth and earnings power of our healthcare business. We had a re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-patient-monitoring-earnings-review-090428202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MASI","RMD.AU","NDAQ","IRTC","PODD",".IXIC","RMD","DXCM"],"gpt_icon":0},{"id":"2525938007","title":"Bell Potter: 4 quality stocks now at a discount","url":"https://stock-news.laohu8.com/highlight/detail?id=2525938007","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525938007?lang=en_us&edition=fundamental","pubTime":"2025-04-08 09:16","pubTimestamp":1744075005,"startTime":"0","endTime":"0","summary":"The one silver lining to widespread market sell-offs is that quality companies can get caught in the crossfire.With uncertainty the order of the day, the quest for quality takes centre stage.Bell Potter has released its pick of the best stock picks that it believes are now undervalued following the recent market turmoil.Sentiment-driven selloffs can impact all stocks, meaning even high-quality, fundamentally sound businesses can experience valuation compression unrelated to their intrinsic worth. This creates valuable windows to buy quality stocks at more reasonable valuations.While valuations have dropped, aggregate market earnings forecasts over the last 6 weeks remain strong, opening the door to buying opportunities.Bell Potter’s “quality at a discount” screen searched for companies based on balance sheet strength, high and sustainable returns on equity and consistent profitability.It then assesses their potential for growth, earnings momentum and looks for stocks with notable P/E c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/bell-potter-4-quality-stocks-now-at-a-discount","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/bell-potter-4-quality-stocks-now-at-a-discount","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["RMD.AU","BK7503","BK7067","BK7501","BK7007","BK4091","ALL.AU","BK7002","GGR","TLX.AU","REA.AU","BK7078","GGR.AU"],"gpt_icon":0},{"id":"1141920108","title":"Stock Track | ResMed Soars 6.81% in Pre-Market as Analyst Confidence Grows","url":"https://stock-news.laohu8.com/highlight/detail?id=1141920108","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141920108?lang=en_us&edition=fundamental","pubTime":"2025-04-08 08:08","pubTimestamp":1744070907,"startTime":"0","endTime":"0","summary":"Shares of ResMed DRC  are surging 6.81% in pre-market trading on Tuesday, building on the momentum from Monday's 3.82% gain. This significant uptick comes as investors seem to be reevaluating the company's long-term prospects in the sleep disorder treatment market.The rally appears to be fueled by growing analyst confidence in ResMed's future. Goldman Sachs has recently reiterated its conviction buy rating on the stock with a price target of $49.00, signaling strong upside potential. Analysts ar","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | ResMed Soars 6.81% in Pre-Market as Analyst Confidence Grows","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["RMD.AU"],"gpt_icon":1},{"id":"2525072907","title":"If I were building my portfolio from scratch, I'd buy these 3 ASX stocks today","url":"https://stock-news.laohu8.com/highlight/detail?id=2525072907","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525072907?lang=en_us&edition=fundamental","pubTime":"2025-04-08 05:04","pubTimestamp":1744059840,"startTime":"0","endTime":"0","summary":"Every investor has to start somewhere. And if I were hitting reset on my portfolio today, I wouldn't be chasing the next big thing or getting lost in the noise — I'd be laying a rock-solid foundation ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/08/if-i-were-building-my-portfolio-from-scratch-id-buy-these-3-asx-stocks-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["IE00B5949003.HKD","LU2452424414.USD","LU2211815571.USD","LU0708995401.HKD","BK4532","LU0251132253.USD","LU1366192091.USD","SGXZ99366536.SGD","LU1935043023.USD","GMG.AU","LU0308772762.SGD","IE00BJLML261.HKD","IE0009G5SDU7.USD","LU2430703095.HKD","LU0256863902.USD","LU0158827781.USD","IE00B19Z9505.USD","IE0004445239.USD","LU1629891620.HKD","LU1935043536.SGD","RMD.AU","LU0215105999.USD","LU0234572021.USD","LU1934455863.HKD","LU2462157665.USD","BK4550","LU0466842654.USD","LU2168563687.JPY","USAW.SI","TNE.AU","LU2592432038.USD","LU0957791311.USD","LU0109392836.USD","IE00BKVL7J92.USD","LU0788109477.HKD","BK4503","BK4592","IE00B19Z8W00.USD","LU0079474960.USD","LU0314104364.USD","LU1037948897.HKD","IE00BQXX3D17.EUR","LU1551013342.USD","LU0823411888.USD","LU1803068979.SGD","LU0494093205.USD","LU0795875169.SGD","LU0077335932.USD","IE00BMPRXN33.USD"],"gpt_icon":1},{"id":"2525071263","title":"ResMed Inc. Stock Rises Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2525071263","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525071263?lang=en_us&edition=fundamental","pubTime":"2025-04-08 04:55","pubTimestamp":1744059300,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  rallied 3.82% to $213.00 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.23% to 5,062.25 and Dow Jones Industrial Average  falling 0.91% to 37,965.60.The stock's rise snapped a two-day losing streak.ResMed Inc. closed 19.03% below its 52-week high of $263.05, which the company achieved on January 30th.Trading volume  eclipsed its 50-day average volume of 1.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 7, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD","RMD.AU"],"gpt_icon":0},{"id":"2525579660","title":"Market shifts and contrarian opportunities: WAM Leaders on “What’s next”","url":"https://stock-news.laohu8.com/highlight/detail?id=2525579660","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525579660?lang=en_us&edition=fundamental","pubTime":"2025-04-07 13:03","pubTimestamp":1744002230,"startTime":"0","endTime":"0","summary":"With uncertainty reshaping the market and momentum trades unwinding, where should investors turn next in the large cap space?Following the 2025 Wilson Asset Management Roadshow, I caught up with Anna Milne, Senior Investment Analyst at WAM Leaders, to tell us about which stocks could struggle, where new opportunities are emerging, and the impact of global headwinds on Australian markets.From overvalued large caps to contrarian opportunities, Milne shares where she sees risks - and where the best risk-adjusted returns might lie. We also look at which sectors are poised for a comeback, the impact of US tariffs, and why quality and value are the winning formula in today’s uncertain landscape.Over the past year, large-cap momentum stocks like Commonwealth Bank , Wesfarmers , and Goodman Group  have enjoyed significant gains. According to Milne, however, market volatility and crowding have triggered a shift in market leadership, leaving these high-flying stocks vulnerable to a pullback.9 AS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/market-shifts-and-contrarian-opportunities-wam-leaders-on-what-s-next","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/market-shifts-and-contrarian-opportunities-wam-leaders-on-what-s-next","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["GMG.AU","BK7042","WTC.AU","CBA.AU","BK7504","BK7099","BK7112","SPK.AU","AMC.AU","ALD.AU","BK7041","BK7153","IAG.AU","RMD.AU","BK7507","BK7135","BK7007","TLS.AU","BK7063","BK7016","BK7501","MIN.AU","WES.AU","BK7503","BK7065","CGF.AU","BK7155","BK7095","BK7126","ANN.AU","BK7034","BK7511","BK7510"],"gpt_icon":0},{"id":"2525035365","title":"2 top quality ASX 200 shares to buy after the market selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2525035365","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525035365?lang=en_us&edition=fundamental","pubTime":"2025-04-07 08:33","pubTimestamp":1743985980,"startTime":"0","endTime":"0","summary":"The ASX 200 index is crashing on Monday following an equally brutal selloff on Wall Street on Friday. While it certainly is a tough time for ASX investors, it could also be one of the best buying oppo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/07/2-top-quality-asx-200-shares-to-buy-after-the-market-selloff/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7067","TLX.AU","BK7007","BK7501","RMD.AU","ROE"],"gpt_icon":1},{"id":"2525741468","title":"Here's a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!","url":"https://stock-news.laohu8.com/highlight/detail?id=2525741468","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525741468?lang=en_us&edition=fundamental","pubTime":"2025-04-06 06:02","pubTimestamp":1743890520,"startTime":"0","endTime":"0","summary":"If you're just getting started on your investing journey and want to build a portfolio with long-term potential, the ASX 200 is a great place to begin. The key is to include a mix of quality companies","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/06/heres-a-starter-portfolio-of-asx-200-shares-to-consider-for-growth-dividends-and-value/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7508","BK7007","BK7128","TWE.AU","MQG.AU","TLS.AU","COL.AU","CSL.AU","GMG.AU","BK7153","WES.AU","BK7067","BK7042","BK7046","BK7041","RMD.AU","BK7099","BK7040","XRO.AU","BK7510","BK7097","BK7505","BK7155","BK7501","BK7503","BK7511","BK7082","BK7016","SUL.AU"],"gpt_icon":1},{"id":"2525575822","title":"10 ASX shares to buy after the market selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2525575822","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525575822?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:07","pubTimestamp":1743797220,"startTime":"0","endTime":"0","summary":"The recent share market selloff has rattled investor confidence — but for those thinking long term, it could be a gift in disguise. When share prices drop across the board, it often has less to do wit","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/05/10-asx-shares-to-buy-after-the-market-selloff/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7040","BK7128","LU0971096721.USD","CSL.AU","LU2028103732.USD","LU1868836757.USD","BK7099","WOW.AU","BK7511","LU0251142724.SGD","BK7155","LOV.AU","XRO.AU","LU0795875086.SGD","LU1732800096.USD","BK4588","GMG.AU","LU2133065610.SGD","BK7007","LU0225283273.USD","LU1074936037.SGD","LU1989772840.SGD","LU1989772923.USD","LU2237443549.SGD","BK4516","BK4552","LU2471134879.HKD","LU2471134796.USD","LU2750360641.GBP","LU2237443465.HKD","LU1868836591.USD","RMD.AU","LU0795875169.SGD","LU1732799900.SGD","LU0314104364.USD","LU1162221912.USD","LU2237443382.USD","LU0061475181.USD","TLX.AU","LU1791807156.HKD","MQG.AU","TNE.AU","LU2237443978.SGD","BK4127","LU1868836914.USD","BK4581","LU2089283258.USD","BK7016","IE00B19Z3581.USD","WTC.AU"],"gpt_icon":0},{"id":"2524278832","title":"Should I buy Fisher & Paykel or ResMed shares?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524278832","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524278832?lang=en_us&edition=fundamental","pubTime":"2025-04-04 11:48","pubTimestamp":1743738489,"startTime":"0","endTime":"0","summary":"Both companies are global leaders with strong track records, but when it comes to deciding which to buy today, the case for ResMed shares looks particularly compelling.Fisher & Paykel is a New Zealand-based medical device company that designs, manufactures and markets equipment used in acute and chronic respiratory care, surgical applications, and sleep apnoea treatment.The company has a presence in more than 120 countries and has built a strong reputation over decades. However, despite the quality of the business, analysts are taking a more measured view for now.Morgan Stanley currently has an equal-weight  rating on the stock with a $36.30 price target, compared to its recent share price of $31.40. That represents some upside, but the broker isn't quite ready to call it a buy.Goldman Sachs recently reaffirmed its conviction buy rating on ResMed shares with a $49.00 price target, well above the current share price of $33.82.For investors looking for growth, value, and global exposure ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/04/should-i-buy-fisher-paykel-or-resmed-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU0096364046.USD","BK4552","LU1791807156.HKD","LU1868836591.USD","LU2237443465.HKD","BK7501","LU2471134796.USD","FPH.NZ","LU0314104364.USD","LU2750360641.GBP","LU2237438978.USD","LU2111349929.HKD","BK4534","LU0158827781.USD","LU1074936037.SGD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU2133065610.SGD","IE00BFXG1179.USD","BK4504","LU0158827948.USD","BK8004","BK4127","LU1548497426.USD","LU0061475181.USD","LU1720051017.SGD","LU1720051108.HKD","RMD.AU","LU2471134879.HKD","BK4533","BK4516","LU0106831901.USD","LU0742534661.SGD","LU0320765646.SGD","BK4588","LU1868837300.USD","IE0004091025.USD","IE00BSNM7G36.USD","IE0004086264.USD","LU0912757837.SGD","LU2237443622.USD","LU0048573561.USD","LU1732800096.USD","RMD","LU2008162690.USD","BK4548","LU2237443978.SGD","FPH.AU","IE00BKVL7J92.USD","LU0225283273.USD"],"gpt_icon":0},{"id":"2524252792","title":"ResMed Launches Home Sleep Apnea Test Across US; Shares Fall 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524252792","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524252792?lang=en_us&edition=fundamental","pubTime":"2025-04-04 11:30","pubTimestamp":1743737426,"startTime":"0","endTime":"0","summary":"ResMed  launched its US Food and Drug Administration-cleared home sleep apnea test, NightOwl, across the US, according to a Friday statement by the company.The fingertip sensor allows individuals to test for obstructive sleep apnea at home, the statement said.Shares of the company fell nearly 3% in recent Friday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CFA.SI","BK4504","BK4585","BK4082","RMD.AU","LU2177674079.SGD","RMD","BK4567","LU2008162690.USD","BK4195","BK4211","BK4588","HBCP","LU0170899867.USD","BK7007","BK4548","BK7501"],"gpt_icon":0},{"id":"2524921642","title":"ResMed Inc. Stock Falls Thursday, Still Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2524921642","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524921642?lang=en_us&edition=fundamental","pubTime":"2025-04-04 04:55","pubTimestamp":1743713700,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  shed 4.33% to $213.35 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 4.84% to 5,396.52 and Dow Jones Industrial Average  falling 3.98% to 40,545.93.ResMed Inc. closed 18.89% short of its 52-week high of $263.05, which the company reached on January 30th.Trading volume  eclipsed its 50-day average volume of 979,704.Data source: Dow Jones Market Data, FactSet. Data compiled April 3, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2524290094","title":"The top 3 qualities I look for when picking an ASX stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2524290094","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524290094?lang=en_us&edition=fundamental","pubTime":"2025-04-04 03:35","pubTimestamp":1743708900,"startTime":"0","endTime":"0","summary":"The Australian share market is home to over 2,000 listed companies — from blue-chip giants to small-cap disruptors and meme stocks — all vying for investor attention. But with so many ASX stock options, how do you separate the long-term winners from the short-term flashes?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/04/the-top-3-qualities-i-look-for-when-picking-an-asx-stock/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["GMG.AU","LOV.AU","BK7128","BK7510","360.AU","TNE.AU","BK7503","MOAT.AU","RMD.AU","WTC.AU","BK7155","BK7016","BK7099","BK7501","BK7007"],"gpt_icon":1},{"id":"2524695475","title":"3 no-brainer ASX 200 shares to buy after the market selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2524695475","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524695475?lang=en_us&edition=fundamental","pubTime":"2025-04-03 08:04","pubTimestamp":1743638672,"startTime":"0","endTime":"0","summary":"The Australian share market is under pressure again today, with investors scrambling in response to US President Donald Trump's controversial new tariff policy. From Saturday, the US will slap a minim","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/03/3-no-brainer-asx-200-shares-to-buy-after-the-market-selloff/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["RMD.AU","BK7007","XJO.AU","BK7046","XKO.AU","MQG.AU","BK7067","BK7508","BK7501","XAO.AU","CSL.AU","BK7511"],"gpt_icon":1},{"id":"2524440874","title":"Resmed Inc. (RMD): Jim Cramer Says He Likes This Sleep Apnea Treatment Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2524440874","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524440874?lang=en_us&edition=fundamental","pubTime":"2025-04-03 05:35","pubTimestamp":1743629734,"startTime":"0","endTime":"0","summary":"We recently published a list of Jim Cramer is Discussing These 10 Stocks Ahead of Q1 Earnings Season. In this article, we are going to take a look at where Resmed Inc.  stands against other stocks that Jim Cramer is discussing ahead of Q1 earnings season.Jim Cramer in a latest program on CNBC talked about the winning sectors so far this year and said the trends show a “strange” pattern. Cramer specifically mentioned the oil and gas sector which he believed would underperform given President Donald Trump’s plan to keep energy prices lower.“I thought this group would be down given that the president wants to expand drill and we have a slower economy, but the stocks aren’t expensive and demand for natural gas very strong,” Cramer said.“The fund’s bigger-than-benchmark position in medical equipment designerResMed Inc.  was the next-largest contributor. ResMed’s primary focus is sleep","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/resmed-inc-rmd-jim-cramer-213534179.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","RSMDF","BK4585","BK4504","BK4548","LU0170899867.USD","LU2008162690.USD","LU2177674079.SGD","BK4567","BK4588","RMD.AU","RMD"],"gpt_icon":0},{"id":"2524465004","title":"Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524465004","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524465004?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:05","pubTimestamp":1743624300,"startTime":"0","endTime":"0","summary":"Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.A replay of the earnings webcast will be accessible on Resmed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from April 23, 2025, until May 7, 2025,at:. About ResmedResmed  creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re rede","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/resmed-report-third-quarter-fiscal-200500756.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["RMD","RMD.AU"],"gpt_icon":0},{"id":"2524502415","title":"The power of compounding: What your ASX share portfolio could become by 2040","url":"https://stock-news.laohu8.com/highlight/detail?id=2524502415","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524502415?lang=en_us&edition=fundamental","pubTime":"2025-04-02 22:30","pubTimestamp":1743604200,"startTime":"0","endTime":"0","summary":"If there's one force in investing that deserves more attention, it is compounding. In simple terms, compounding is when your returns start generating returns of their own. And over time, that snowballs into something pretty remarkable. So, what happens when you combine compounding with a long-term mindset, a regular investment plan, and a healthy dose of quality ASX shares?Let's take a look. The ASX share plan Let's imagine you're starting with $10,000 in savings and can invest $500 a month into the share market. You're committed to this strategy until 2040, which gives you 15 years of consistent investing. And while nothing in the market is guaranteed, we'll assume a 10% average annual return, which is in line with historical long-term returns for the Australian share market, including dividends. Here's what that could look like:  Starting amount: $10,000 Monthly investment: $500 Time horizon: 15 years Annual return : 10%  By 2040, your ASX portfolio could grow to a jaw-dropping $240,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/03/the-power-of-compounding-what-your-asx-share-portfolio-could-become-by-2040/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7099","RMD.AU","BK7016","BK7503","BK4585","BK4550","CSL.AU","BK7007","TNE.AU","BK4588","XJO.AU","BK7511","BK7508","BK7067","GMG.AU","XAO.AU","AQLT.AU","FDN","MOAT.AU","BK7510","XKO.AU","BK7155","BK7501","VAS.AU"],"gpt_icon":1},{"id":"2524381178","title":"Resmed Chief Legal Officer Sells Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2524381178","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524381178?lang=en_us&edition=fundamental","pubTime":"2025-04-02 07:02","pubTimestamp":1743548577,"startTime":"0","endTime":"0","summary":"Resmed (ASX:RMD) Chief Legal Officer Michael Rider sold 64 common shares on the New York Stock Exchange for $14,263, according to a Wednesday filing with the Australian bourse.Following the sale of shares, Rider owns about 146.9 million shares in the company, per the filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","BK4585","LU0170899867.USD","BK4504","RMD.AU","XAO.AU","XJO.AU","BK4082","RMD","XKO.AU","BK7007","BK7501","LU2177674079.SGD","BK4588","LU2008162690.USD","BK4567"],"gpt_icon":0},{"id":"2524970555","title":"ResMed Inc. Stock Rises Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2524970555","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524970555?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:56","pubTimestamp":1743454560,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  advanced 1.78% to $223.85 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.55% to 5,611.85 and the Dow Jones Industrial Average  rising 1.00% to 42,001.76.ResMed Inc. closed 14.90% below its 52-week high of $263.05, which the company achieved on January 30th.Trading volume  eclipsed its 50-day average volume of 982,555.Data source: Dow Jones Market Data, FactSet. Data compiled March 31, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2523593593","title":"Don't waste this market selloff: Why now could be the time to buy ASX shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2523593593","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523593593?lang=en_us&edition=fundamental","pubTime":"2025-03-31 08:00","pubTimestamp":1743379200,"startTime":"0","endTime":"0","summary":"It certainly has been a rough ride for ASX shares in recent weeks. From global tech weakness to renewed trade tensions and ongoing macro uncertainty, investors have had no shortage of reasons to stay on the sidelines. But for long-term thinkers, this kind of market backdrop isn't a reason to panic — it is a reason to prepare. Because if history has taught us anything, it is that periods of market fear often create the best opportunities for future gains from ASX shares. So, with the ASX 200 index opening the week deep in the red with another market selloff, is now the time to take action?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/31/dont-waste-this-market-selloff-why-now-could-be-the-time-to-buy-asx-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7016","BK7501","NXT.AU","BK7099","GMG.AU","BK7503","WTC.AU","LOV.AU","BK7043","RMD.AU","BK7510","BK7007","BK7155","BK7128"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RMD.AU\",params:#limit:5,,,undefined,":[{"date":"2025-05-07","symbol":"RMD.AU","amount":0.053,"announcedDate":"2025-04-24","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-05-08","defaultRemindTime":1746576000000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-12","payableDate":"2025-05-08","currency":"USD","dateTimestamp":1746540000000,"payDate":"2025-06-12"},{"date":"2025-02-12","symbol":"RMD.AU","amount":0.053,"announcedDate":"2025-01-31","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-02-13","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-02-13","currency":"USD","dateTimestamp":1739278800000,"payDate":"2025-03-20"},{"date":"2024-11-06","symbol":"RMD.AU","amount":0.053,"announcedDate":"2024-10-25","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-11-07","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-11-07","currency":"USD","dateTimestamp":1730811600000,"payDate":"2024-12-12"},{"date":"2024-08-14","symbol":"RMD.AU","amount":0.053,"announcedDate":"2024-08-02","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-08-15","defaultRemindTime":1723593600000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-19","payableDate":"2024-08-15","currency":"USD","dateTimestamp":1723557600000,"payDate":"2024-09-19"},{"date":"2024-05-08","symbol":"RMD.AU","amount":0.048,"announcedDate":"2024-04-26","type":"dividend","market":"AU","newRecordDate":"2024-05-09","defaultRemindTime":1715126400000,"name":"Resmed DRC","recordDate":"2024-06-13","payableDate":"2024-05-09","currency":"USD","dateTimestamp":1715090400000,"payDate":"2024-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RMD.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-08-19","recordDate":"2020-08-20","paymentDate":"2020-09-24","value":0.039,"currency":"USD"},{"executeDate":"2020-11-11","recordDate":"2020-11-12","paymentDate":"2020-12-17","value":0.039,"currency":"USD"},{"executeDate":"2021-02-10","recordDate":"2021-02-11","paymentDate":"2021-03-18","value":0.039,"currency":"USD"},{"executeDate":"2021-05-12","recordDate":"2021-05-13","paymentDate":"2021-06-17","value":0.039,"currency":"USD"},{"executeDate":"2021-08-18","recordDate":"2021-08-19","paymentDate":"2021-09-23","value":0.042,"currency":"USD"}]}}